Literature DB >> 28462697

Insight Mechanism of the Selective Lanosterol Synthase Inhibitor: Molecular Modeling, Docking and Density Functional Theory Approaches.

Subramanian Karunagaran1, Rengarajan Kavitha2, Muthu Vadivelu1, Keun Woo Lee3, Chandrasekaran Meganathan1.   

Abstract

BACKGROUND: Lanosterol synthase (Oxidosqualene cyclase) is an enzyme, which plays a central role in cholesterol and sterols biosynthesis. Lanosterol synthase drugs are used to lower the level of cholesterol in the blood and treat wide variety of diseases like atherosclerosis, coronary heart diseases etc.
OBJECTIVE: There is a great interest in the identification of drugs that target this enzyme for anticholesteraemic agent using in silico tools.
METHODS: Ligand based pharmacophore model was developed using Discovery Studio 2.5. The best model was used as a tool to retrieve suitable molecule for Lanosterol synthase inhibitor from commercial database and Virtual screening of large commercially available databases to retrieve the best mole of Hypo1 using. Molecular docking was done using three different tools named as GOLD, GLIDE and AUTODOCK 4.0. Density functional theory approach and Density of State spectrum were carried out using Gaussian 09 and GAUSS SUM 3.0. Contribution of these methods in the selection of anticholesteraemic compounds has been discussed.
RESULTS: The best pharmacophore model was used to screen the commercial database. Totally 8 compounds were showed with the best orientation, binding mode and binging energy in the docking analyses. The orbital energies such as HOMO, LUMO and DOS spectrum for 8 hit compounds showed the energy gap that results in charge transfer and stability in the active site region. The results showed that our 8 potent leads could serve for further findings.
CONCLUSION: In silico approaches, our 8 hit compounds could serve as the better understanding to design the novel lanosterol synthase inhibitors as anticholesteraemic activity. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Lanosterol synthase; atherosclerosis.; density function theory; molecular docking; pharmacophore modeling; virtual screening

Mesh:

Substances:

Year:  2017        PMID: 28462697     DOI: 10.2174/1573409913666170426153509

Source DB:  PubMed          Journal:  Curr Comput Aided Drug Des        ISSN: 1573-4099            Impact factor:   1.606


  4 in total

1.  Bi-allelic Mutations in LSS, Encoding Lanosterol Synthase, Cause Autosomal-Recessive Hypotrichosis Simplex.

Authors:  Maria-Teresa Romano; Aylar Tafazzoli; Maximilian Mattern; Sugirthan Sivalingam; Sabrina Wolf; Alexander Rupp; Holger Thiele; Janine Altmüller; Peter Nürnberg; Jürgen Ellwanger; Reto Gambon; Alessandra Baumer; Nicolai Kohlschmidt; Dieter Metze; Stefan Holdenrieder; Ralf Paus; Dieter Lütjohann; Jorge Frank; Matthias Geyer; Marta Bertolini; Pavlos Kokordelis; Regina C Betz
Journal:  Am J Hum Genet       Date:  2018-10-25       Impact factor: 11.025

2.  Effects of Fdft 1 gene silencing and VD3 intervention on lung injury in hypoxia-stressed rats.

Authors:  Xiaoyan Pu; Xue Lin; Yinglian Qi; Yinglian Li; Tiantian Li; Yang Liu; Dengbang Wei
Journal:  Genes Genomics       Date:  2022-08-10       Impact factor: 2.164

3.  Differential metabolic and multi-tissue transcriptomic responses to fructose consumption among genetically diverse mice.

Authors:  Guanglin Zhang; Hyae Ran Byun; Zhe Ying; Montgomery Blencowe; Yuqi Zhao; Jason Hong; Le Shu; Karthick Chella Krishnan; Fernando Gomez-Pinilla; Xia Yang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-10-25       Impact factor: 5.187

4.  Computer-aided drug design, synthesis and identification of disulfide compounds as novel and potential allosteric PAK1 inhibitors.

Authors:  Hanwei Huang; Hailun Jiang; Xiangyu Zhang; Wei Li; Pengliang Wang; Funan Liu; Jian Wang; Mingfeng Bai; Maosheng Cheng
Journal:  RSC Adv       Date:  2018-03-27       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.